Frontier Pharma Asthma Therapeutics strategies and Product Pipeline Review 2017

Market Overview of Frontier Pharma Asthma pipeline Landscape

PUNE, INDIA, May 30, 2017 /EINPresswire.com/ — Summary
Asthma is a chronic condition affecting the respiratory system, with disease occurrence linked to both genetic and environmental factors. It has significant global incidence and there is currently no cure. Pharmacotherapeutic intervention aims to provide patients with an increased level of disease control and reduce the severity of symptoms, and a number of inhalational therapeutic options are available. Current asthma treatment options are able to provide the majority of patients with a sufficient level of disease control. Additionally, scientific advancements through the development of combination and add-on therapeutics have provided patients with treatments that allow for a greater level of disease control. However, unmet need remains, in the form of patients that do not respond well to current therapeutics or therapeutic combinations. This group of patients accounts for the vast majority of global healthcare costs associated with asthma. Pipeline product development aims to improve upon current therapeutic options and provide options for satisfactory disease control to patients with unmet needs. This is reflected in the high number of products in development, with 287 pipeline products, accounting for just over a third of products within the broader respiratory therapy area pipeline. There are a total of 93 first-in-class pipeline products in development for asthma, representing a substantial 44% of the 212 pipeline products for which there is a disclosed molecular target. A number of these first-in-class pipeline programs appear to have significant potential to strengthen the asthma treatment landscape – as well as representing promising commercial opportunities. A large number of first-in-class products in the current asthma pipeline have not previously been involved in licensing or co-development deals. This highlights the significant opportunities in the asthma pipeline, and the many possibilities for high-risk, high-reward investment.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/782018-frontier-pharma-asthma-therapeutics-in-class-innovation

Scope
– Analysis of innovation in the asthma market in the context of the overall pipeline and current market landscape – also includes analysis of the deals landscape surrounding first-in-class products in asthma, and highlights opportunities for in-licensing
– A brief introduction to asthma, including symptoms, pathophysiology, and an overview of pharmacotherapy
– The changing molecular target landscape between the market and the pipeline, and particular focal points of innovation in the pipeline
– Comprehensive review of the pipeline for first-in-class therapies, analyzed on the basis of stage of development, molecule type and molecular target
– Identification and assessment of first-in-class molecular targets, with a particular focus on early-stage programs for which clinical utility has yet to be evaluated, as well as literature reviews on novel molecular targets
– Assessment of the licensing and co-development deal landscape for asthma therapies, and benchmarking of deals involving first-in-class versus non-first-in-class-products

Reasons to buy
– Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment strategies currently available.
– Visualize the composition of the asthma market in terms of the dominant classes of therapies. Unmet needs are highlighted to allow a competitive understanding of current gaps in the market.
– Analyze the asthma pipeline and stratify pipeline therapies by stage of development, molecule type and molecular target. There are signs in the pipeline that the industry is seeking novel approaches to meet unmet needs within asthma.
– Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been further reviewed in greater detail.
– Identify commercial opportunities in the asthma deals landscape by analyzing trends in licensing and co-development deals and assessing asthma therapies that are not yet involved in deals, and may be potential investment opportunities.

Table of Content: Key Points
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Executive Summary 5
2.1 Biologics and mAbs Growing in Prominence in Asthma Treatment 5
2.2 Market Landscape to Grow in Diversity over Coming Years 5
2.3 Cytokine and Kinase Targeted Small Molecules and mAbs Dominate First-in-Class Innovation 5
2.4 Deals Landscape Offers Significant Investment Opportunities for First-in-Class Products 5
3 The Case for Innovation in the Asthma Market 6
4 Clinical and Commercial Landscape 10
5 Assessment of Pipeline Product Innovation 23
6 Signaling Network and Innovation Alignment 33
7 First-in-Class Target Evaluation 36
…Continued

Access Report @ https://www.wiseguyreports.com/reports/782018-frontier-pharma-asthma-therapeutics-in-class-innovation

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Cancer Supportive Care Therapeutics Development and Professional Review Analysis 2017

Cancer Supportive Care Pharmaceutical and Healthcare Pipeline Review H1

PUNE, INDIA, May 30, 2017 /EINPresswire.com/ — Summary
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life. The key indications covered in this report are cancer pain, oral mucositis, chemotherapy-induced neutropenia (CIN), chemotherapy-induced anemia (CIA), chemotherapy-induced nausea and vomiting (CINV) and bone metastasis. These indications are not only distressing for patients, but can also lead to treatment cessation, which in turn increases patient mortality. As the number of people being diagnosed with cancer grows and access to effective treatment that allows patients to survive longer increases, demand for safe and effective cancer supportive care drugs will rise.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1224092-global-cancer-supportive-care-therapeutics-market-to-2022-patent-expirations-create

The majority of indications targeted by cancer supportive care products are the direct result of a patient receiving chemotherapy in an attempt to cure their cancer or relieve symptoms. It is often the case that the most effective chemotherapy regimens result in the most severe symptoms. This increases the need for cancer supportive care products, which can improve patient outcomes by providing greater tolerance to the most effective regimens. Bone metastasis and most forms of cancer pain are not caused by chemotherapy or cancer treatment, and are instead often a symptom of the cancer itself, occurring in a high proportion of cancer patients.

The level of unmet need within the cancer supportive care therapy area varies between indications. CIN and CINV both already have treatment regimens that can significantly decrease the incidence rate. However, the level of unmet need for CIA, cancer pain, oral mucositis and bone metastasis is high, with treatment focusing heavily on alleviating the symptoms instead of treating the underlying cause.

There are 245 products in active development in the cancer supportive care pipeline, but this includes products in development for smaller and less commercially significant indications. There are 169 products in active development for the key indication examined in this report, giving an average of 28 products per indication, the majority of which are at an early stage of development.

Scope
The cancer supportive care market already contains some commercially successful products.
– Which classes of drug dominate the market?
– Which indication is the most commercially successful?
– How will commercially successful drugs perform over the forecast period?
The cancer supportive care pipeline is relatively small, but there is significant diversity in terms of molecule types and targets.
– Which molecular targets appear most frequently in the pipeline?
– What are the commercial prospects for the most promising late-stage pipeline products?
The cancer supportive care market is forecast to grow from $11.7 billion in 2015 to $12.4 billion in 2022, at a compound annual growth rate of 0.9%.
– Which products are forecast to drive growth?
– Will generic and biosimilar competition have a significant impact on the market over the forecast period?
The company landscape is becoming increasingly competitive.
– What are the leading companies in terms of market share?
– Which companies are forecast to experience the greatest growth in market share?
– What are the drivers of growth for key companies in the market?
– How dependent are the key companies on this disease cluster for revenue?

Reasons to buy
This report will allow you to –
– Understand the current clinical and commercial landscape through a comprehensive study of disease pathogenesis, symptoms, diagnosis and prognosis for the key indications covered in the report
– Understand the current treatment landscape, with profiles of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
– Identify the key pipeline products, with a particular focus on those due to be brought to market in the near future, as well as sales forecasts for these products.
– Predict growth in market size, with in-depth market forecasting from 2015 to 2022. The forecast will provide an understanding of how epidemiology trends, new drug entries and new drug patents expirations will influence market value.
– Identify the leading companies in the market, in terms of market share and growth. Company analysis illustrates how dependent the key companies in the market are on revenue derived from cancer supportive care products. In addition, analysis determines the primary factors that will drive market growth for the key companies in the market.
– Identify commercial opportunities in the cancer supportive care deals landscape by analyzing trends in licensing and co-development deals.

Table of Content: Key Points
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 10
2.1 Therapy Area Introduction 10
2.2 Epidemiology 10
2.2.1 Cancer Pain 10
2.2.2 Chemotherapy Side Effects 11
2.2.3 Oral Mucositis 11
2.3 Pathophysiology 11
2.3.1 Bone Metastasis 11
2.3.2 Oral mucositis 12
2.3.3 Cancer Pain 12
2.3.4 Chemotherapy-Induced Nausea and Vomiting 12
2.3.5 Chemotherapy-Induced Anemia 13
2.3.6 Chemotherapy-Induced Neutropenia 13
2.4 Etiology 13
2.5 Symptoms 14
2.6 Diagnosis and Grading 14
2.7 Treatment 17
2.7.1 Chemotherapy-Induced Nausea and Vomiting 17
2.7.2 Chemotherapy-Induced Neutropenia 18
2.7.3 Chemotherapy-Induced Anemia 18
2.7.4 Cancer Pain 19
2.7.5 Bone Metastases 19
2.7.6 Oral Mucositis 19
3 Key Marketed Products 21
3.1 Overview 21
3.2 Neulasta (pegfilgrastim) – Amgen 22
3.3 Xgeva (denosumab) – Amgen 23
3.4 Aranesp/Nesp (darbepoetin alfa) – Amgen/Kyowa Hakko Kirin 24
3.5 Xofigo (radium Ra 223 dichloride) – Bayer 26
3.6 Nucynta (tapentadol hydrochloride) – Depomed 27
3.7 Epogen/Procrit (epoetin alfa) – Amgen/Johnson & Johnson 29
3.8 Neupogen (Filgrastim) – Amgen 30
3.9 Aloxi (palonosetron hydrochloride) – Eisai, Helsinn and Otsuka 32
3.10 Conclusion 33
4 Pipeline Landscape Assessment 35
4.1 Overview 35
4.2 Pipeline Development Landscape 35
4.3 Molecular Targets in the Pipeline 38
4.4 Clinical Trials 40
5 Multi-scenario Market Forecast to 2022 62
5.3.2 G Protein-Coupled Receptors 68
6 Company Analysis and Positioning 70
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1224092-global-cancer-supportive-care-therapeutics-market-to-2022-patent-expirations-create

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Global Hip and Knee Orthopedic Surgical Robots Market 2017 Industry Trend and Forecast 2022

“Hip and Knee Orthopedic Surgical Robots Market: Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Database

PUNE, INDIA, May 30, 2017 /EINPresswire.com/ — Global Hip and Knee Orthopedic Surgical Robots Industry

Latest Report on Hip and Knee Orthopedic Surgical Robots Market Global Analysis & 2022 Forecast Research Study

Notes:
Production, means the output of Hip and Knee Orthopedic Surgical Robots
Revenue, means the sales value of Hip and Knee Orthopedic Surgical Robots

This report studies Hip and Knee Orthopedic Surgical Robots in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Stryker/Mako
Smith & Nephew
Zimmer Biomet
THINK Surgical
Wright Medical Technology
Shenzhen Advanced Institute Spinal Surgical Robot

Try Sample Report @ https://www.wiseguyreports.com/sample-request/951111-global-hip-and-knee-orthopedic-surgical-robots-market-research-report-2017

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Hip and Knee Orthopedic Surgical Robots in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by application, this report focuses on consumption, market share and growth rate of Hip and Knee Orthopedic Surgical Robots in each application, can be divided into
Application 1
Application 2

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/951111-global-hip-and-knee-orthopedic-surgical-robots-market-research-report-2017

Some Major Points from Table of content:

Global Hip and Knee Orthopedic Surgical Robots Market Research Report 2017
1 Hip and Knee Orthopedic Surgical Robots Market Overview
1.1 Product Overview and Scope of Hip and Knee Orthopedic Surgical Robots
1.2 Hip and Knee Orthopedic Surgical Robots Segment by Type
1.2.1 Global Production Market Share of Hip and Knee Orthopedic Surgical Robots by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.3 Hip and Knee Orthopedic Surgical Robots Segment by Application
1.3.1 Hip and Knee Orthopedic Surgical Robots Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Hip and Knee Orthopedic Surgical Robots Market by Region
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Hip and Knee Orthopedic Surgical Robots (2012-2022)

2 Global Hip and Knee Orthopedic Surgical Robots Market Competition by Manufacturers
2.1 Global Hip and Knee Orthopedic Surgical Robots Production and Share by Manufacturers (2015 and 2016)
2.2 Global Hip and Knee Orthopedic Surgical Robots Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Hip and Knee Orthopedic Surgical Robots Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Hip and Knee Orthopedic Surgical Robots Manufacturing Base Distribution, Sales Area and Product Type
2.5 Hip and Knee Orthopedic Surgical Robots Market Competitive Situation and Trends
2.5.1 Hip and Knee Orthopedic Surgical Robots Market Concentration Rate
2.5.2 Hip and Knee Orthopedic Surgical Robots Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Hip and Knee Orthopedic Surgical Robots Production, Revenue (Value) by Region (2012-2017)
3.1 Global Hip and Knee Orthopedic Surgical Robots Production by Region (2012-2017)
3.2 Global Hip and Knee Orthopedic Surgical Robots Production Market Share by Region (2012-2017)
3.3 Global Hip and Knee Orthopedic Surgical Robots Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Hip and Knee Orthopedic Surgical Robots Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Hip and Knee Orthopedic Surgical Robots Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Hip and Knee Orthopedic Surgical Robots Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Hip and Knee Orthopedic Surgical Robots Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Hip and Knee Orthopedic Surgical Robots Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Hip and Knee Orthopedic Surgical Robots Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Hip and Knee Orthopedic Surgical Robots Production, Revenue, Price and Gross Margin (2012-2017)

If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/951111-global-hip-and-knee-orthopedic-surgical-robots-market-research-report-2017

4 Global Hip and Knee Orthopedic Surgical Robots Supply (Production), Consumption, Export, Import by Regions (2012-2017)
4.1 Global Hip and Knee Orthopedic Surgical Robots Consumption by Regions (2012-2017)
4.2 North America Hip and Knee Orthopedic Surgical Robots Production, Consumption, Export, Import (2012-2017)
4.3 Europe Hip and Knee Orthopedic Surgical Robots Production, Consumption, Export, Import (2012-2017)
4.4 China Hip and Knee Orthopedic Surgical Robots Production, Consumption, Export, Import (2012-2017)
4.5 Japan Hip and Knee Orthopedic Surgical Robots Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Hip and Knee Orthopedic Surgical Robots Production, Consumption, Export, Import (2012-2017)
4.7 India Hip and Knee Orthopedic Surgical Robots Production, Consumption, Export, Import (2012-2017)

5 Global Hip and Knee Orthopedic Surgical Robots Production, Revenue (Value), Price Trend by Type
5.1 Global Hip and Knee Orthopedic Surgical Robots Production and Market Share by Type (2012-2017)
5.2 Global Hip and Knee Orthopedic Surgical Robots Revenue and Market Share by Type (2012-2017)
5.3 Global Hip and Knee Orthopedic Surgical Robots Price by Type (2012-2017)
5.4 Global Hip and Knee Orthopedic Surgical Robots Production Growth by Type (2012-2017)

6 Global Hip and Knee Orthopedic Surgical Robots Market Analysis by Application
6.1 Global Hip and Knee Orthopedic Surgical Robots Consumption and Market Share by Application (2012-2017)
6.2 Global Hip and Knee Orthopedic Surgical Robots Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

Continued…..

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Waist Support Market 2017 Share, Trend, Segmentation and Forecast to 2022

Wiseguyreports.Com Adds “Waist Support Market: Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database

PUNE, INDIA, May 30, 2017 /EINPresswire.com/ — Global Waist Support Industry

Latest Report on Waist Support Market Global Analysis & 2022 Forecast Research Study

Notes:
Production, means the output of Waist Support
Revenue, means the sales value of Waist Support

This report studies Waist Support in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
LP
McDavid
FUTURO
AQ
Mueller
Jiahe

Try Sample Report @ https://www.wiseguyreports.com/sample-request/911671-global-waist-support-market-research-report-2017

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Waist Support in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by application, this report focuses on consumption, market share and growth rate of Waist Support in each application, can be divided into
Application 1
Application 2

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/911671-global-waist-support-market-research-report-2017

Some Major Points from Table of content:

Global Waist Support Market Research Report 2017
1 Waist Support Market Overview
1.1 Product Overview and Scope of Waist Support
1.2 Waist Support Segment by Type
1.2.1 Global Production Market Share of Waist Support by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.3 Waist Support Segment by Application
1.3.1 Waist Support Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.4 Waist Support Market by Region
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Waist Support (2012-2022)

2 Global Waist Support Market Competition by Manufacturers
2.1 Global Waist Support Production and Share by Manufacturers (2015 and 2016)
2.2 Global Waist Support Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Waist Support Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Waist Support Manufacturing Base Distribution, Sales Area and Product Type
2.5 Waist Support Market Competitive Situation and Trends
2.5.1 Waist Support Market Concentration Rate
2.5.2 Waist Support Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/911671-global-waist-support-market-research-report-2017

3 Global Waist Support Production, Revenue (Value) by Region (2012-2017)
3.1 Global Waist Support Production and Market Share by Region (2012-2017)
3.2 Global Waist Support Revenue (Value) and Market Share by Region (2012-2017)
3.3 Global Waist Support Production, Revenue, Price and Gross Margin (2012-2017)
3.4 North America Waist Support Production, Revenue, Price and Gross Margin (2012-2017)
3.5 Europe Waist Support Production, Revenue, Price and Gross Margin (2012-2017)
3.6 China Waist Support Production, Revenue, Price and Gross Margin (2012-2017)
3.7 Japan Waist Support Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Southeast Asia Waist Support Production, Revenue, Price and Gross Margin (2012-2017)
3.9 India Waist Support Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Waist Support Supply (Production), Consumption, Export, Import by Regions (2012-2017)
4.1 Global Waist Support Consumption by Regions (2012-2017)
4.2 North America Waist Support Production, Consumption, Export, Import (2012-2017)
4.3 Europe Waist Support Production, Consumption, Export, Import (2012-2017)
4.4 China Waist Support Production, Consumption, Export, Import (2012-2017)
4.5 Japan Waist Support Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Waist Support Production, Consumption, Export, Import (2012-2017)
4.7 India Waist Support Production, Consumption, Export, Import (2012-2017)

5 Global Waist Support Production, Revenue (Value), Price Trend by Type
5.1 Global Waist Support Production and Market Share by Type (2012-2017)
5.2 Global Waist Support Revenue and Market Share by Type (2012-2017)
5.3 Global Waist Support Price by Type (2012-2017)
5.4 Global Waist Support Production Growth by Type (2012-2017)

Continued…..

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Bio Polymers Market is Expected to Grow at USD 6.37 Billion by 2023

Bio Polymers Market is expected to witness a significant growth of USD ~ 6.37 billion by 2023 with CAGR of ~12.05 % between 2016 and 2023

Bio Polymers Market is expected to witness a significant growth of USD ~ 6.37 billion by 2023 with CAGR of ~12.05 % between 2016 and 2023”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, May 30, 2017 /EINPresswire.com/ — Bio polymers is expected to witness a significant growth of USD ~ 6.37 billion by 2023 with CAGR of ~12.05 % between 2016 and 2023

Market Highlight
The global bio polymers market has been segmented into types, application and end use industries. On the basis of types, the global bio polymers market is segmented into bio- polyethylene (PE), bio- polyethylene terephthalate (PET), poly lactic acid (PLA), polyhydroxyalkanoate (PHA), biodegradable polyesters, and others (regenerated cellulose, starch blends). Among all poly lactic acid bio polymer segment is one of the fastest growing segments in the global biopolymers market and will continue to lead the market over the forecasted period. Furthermore, poly lactic acid bio polymers are water-resistant and decompose within three weeks when subjected to the industrial composting process. Therefore, poly lactic acid bio polymers finds widespread applications in domestic and various end user industry such as, packaging sector, injection molding, film and sheet casting. The increased demand from the bottling and packaging industries is expected to boost the market for poly lactic acid bio polymers in the global biopolymers market.

Request for Sample Report@ https://www.marketresearchfuture.com/sample_request/2977

Key Player
• BASF SE (Europe)
• Braskem S.A (UK)
• Biome Technologies plc (UK)
• Plantic Technologies Limited (Austrelia)
• Bio-on S.p.A. (Europe)
• Novamont S.P.A (Europe)
• Toray Industries Inc (Japan)
• Tianjin GreenBio Materials Co., Ltd (Japan)
• Danimer Scientific (US)
• Rodenburg Biopolymers (US)

Regional Analysis
Asia Pacific is the largest market of bio polymers in terms of production especially in China region. The Second largest market in terms of production is Europe followed by North America. In terms of consumption global bio polymers market is led by Europe region due to demand in various applications such as packaging and pharmaceutical industry. Second position is held by APAC region and the third largest market of bio polymers is North America. Latin America and Middle East also witnessed in growth of bio polymers market due to various application such as films, bottles, bottles, fibers, seed coating, vehicle components, medical implants, and others.

Segmentation
The global bio polymers market is majorly segmented on the basis of types, application, end users and region. Based on types bio polymers the market is segmented into bio- polyethylene (PE), bio- polyethylene terephthalate (PET), poly lactic acid (PLA), polyhydroxyalkanoate (PHA), biodegradable polyesters, and others (regenerated cellulose, starch blends). Based on application of bio polymers the market is segmented into films, bottles, bottles, fibers, seed coating, vehicle components, medical implants, and others (printed circuit boards, audio devices, fuel and exhaust system). Based on end user the market segmented into packaging, agriculture, automotive, pharmaceutical, construction, and others (electronics, personal care, sports), and based on region market is segmented into North America, Europe, APAC, Latin America, Middle East & Africa.

Browse Full B-P Market Report @ https://www.marketresearchfuture.com/reports/bio-polymers-market-2977

Geographic Analysis
The report covers brief analysis of geographical region such as:
North America
• US
• Canada
Europe
• Germany
• France
• Italy
• Netherlands
• U.K.
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• South America
• Middle East
• Africa

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Personalized Medicine, Targeted Therapeutics & Healthcare Market to 2021

.

.

Personalized Medicine Pharmaceutical and Healthcare 2021

PUNE, INDIA, May 30, 2017 /EINPresswire.com/ — Description
Personalized Medicine. Targeted Therapeutics and Companion Diagnostic Market- A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment to 2021” (published May 2017)
Research forecasts that the companion diagnostic and targeted therapeutic submarkets of the personalized medicine industry were worth $113 billion in 2016, and will hit over $162 billion by 2021 with a CAGR of 8.74%. The total personalised therapeutic market, for all indications, will be worth $x billion by 2021, with a CAGR of x%. Currently it is estimated that the companion diagnostic segment is worth $x billion globally, mainly coming from oncology, cardiovascular and infectious disease (HIV/HCV) tests. This is set to rise vertically over the next five years and by 2021 will be worth over $x billion, with a CAGR of x%.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/reports/1309114-personalized-medicine-targeted-therapeutics-companion-diagnostic-market-to-2021

Advancing technologies within the liquid biopsy market is also driving the market and will see strategic growth over the next five years with a CAGR of 20.6%. The two segments of the liquid biopsy market are tumor cell enrichment products and tumor cell detection technologies.
Individualized, targeted or personalized medicine aims to increase the efficacy of therapeutics via genetic testing and companion diagnostics. Personalized therapeutics and associated companion diagnostics are more specific and effective thereby giving pharma/biotech companies a significant advantage to recuperate R&D costs. Personalized medicine reduces the frequency of adverse drug reactions and therefore has a dramatic impact on health economics. Developmental and diagnostic companies benefit from lower discovery and commercialization costs and more specific market subtypes.
This new report gives a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 360 tables & figures over 397 pages. The personalized medicine market is presented as follows:
By Company (e.g., QIAGEN, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD)
By Segment (Targeted therapeutics, Companion Diagnostics)
By Sub-market (Companion diagnostic, targeted cancer therapeutic, medical technology, pharmacogenomics, consumer genomics, molecular diagnostics, liquid biopsy)
By Therapy (Cancer, Cardiovascular, Infectious Disease)

Key Opinion Leaders that contributed to interview questions within the report include:

Iain D. Miller, PhD, MBA, Founder & CEO, Healthcare Strategies Group
Stephen Finn, MBBS, PhD, Associate Professor, Cancer Molecular Diagnostic Laboratory, Consultant Histopathologist and Head of Histopathology, St James’s Hospital and Trinity College Dublin, Ireland
Ronald Przygodzki, MD, Director, Genomic Medicine Implementation at U.S. Department of Veterans Affairs, Washington DC
Elaine Kenny, PhD, Founder, Elda Biotech, Dublin, Ireland
Chad Clark, Co-President and Chief Operating Officer, Precision for Medicine
Tobias Guennel, PhD, Principal, Biomarker and IVD Analytics, Precision for Medicine
David Parker, PhD, Vice President, Integrated Market Access, Precision for Medicine
Deborah Phippard, PhD, Vice President, Research, Precision for Medicine
Judi Smith, MS, Vice President, In Vitro Diagnostics Regulatory and Quality, Precision for Medicine
A wealth of financial data & business strategy information is provided including:
Company Financials, Sales & Revenue Figures
Business Model Strategies for Diagnostic, Pharmaceutical and Biotechnology Companies
Business Model Strategies for Providers. Provider Systems and Academic Medical Centres
Business Model Strategies for Payers & Governments
Private and Public Funding and Personalized Medicine Reimbursement
Revisions to Current Payment Systems and Intellectual Property
How to Gain Market Penetration in the EU
Cost-effectiveness and Business Value of Personalized Medicine
Consumer genomics and POC market
Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations)
Comprehensive Account of Company Product Portfolios & Kits
SWOT, Economic & Regulatory Environment specifics include:
Key Strengths, Weaknesses and Threats Influencing Leading Player Position within the Market
Technologies Driving the Market (e.g., New-Generation Sequencing Technologies, Ultra-High Throughput Sequencing)
Top Fastest Growing Market Segments and Emerging Opportunities
Top Pharmaceutical Companies within the IPM by Market Share and Revenue
Comprehensive Product Portfolios, R&D Activity and Pipeline Therapeutics
M&A Activity and Future Strategies of Top Personalized Medicine Pharmacos
Personalized Medicine Regulation (UK, Germany, France, Spain, Italy)
CE-Marked Personalized Medicine/Diagnostic Tests
FDA Advances in Personalized Medicine Regulation
This report highlights a number of significant players and influential company’s and gives details of their operations, products, financials and business strategy.
23andMe
Abbott Laboratories
Abbott Molecular Inc.
Admera Health (GENEWIZ)
Affymetrix
Agendia
Alere
Amgen
Astex Pharmaceuticals
AstraZeneca
Atossa Genetics
Becton Dickenson
bioMerieux
BristolMyersSquibb
Cancer Genetics
Celera (Quest Diagnostics)
Celldex Therapeutics
Claritas Genomics
CuraGen
Danaher (Leica Biosystems)
deCode Genetics (Amgen)
Foundation Medicine
EDP Biotech
Eli Lilly
ELDA BioTech
Eisai
Genelex
GlaxoSmithKline
Human Longevity Inc (Cypher Genomics)
HalioDx
Ikonisys
Illumina
InterGenetics
Johnson & Johnson
LabCorp
Life Technologies
Merck
MDxHealth
MolecularMD Corporation
Monogram Biosciences
Myriad
Updates on the personalized medicine, targeted therapeutic and companion diagnostic space have been included in this latest edition to include cutting edge material from international conferences, workshops and symposia.
Who should read this report?
Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine
Industry professionals and business strategists will discover key information to propel their policies
Investors will gain inside information to dominant players in the industry and future forecasts
Scientists will get a business perspective and industry insight into how scientific breakthroughs influence the market environment

This report will tell you if the companies mentioned are:
Strong, competitive players
Pooling their resources for specific growth and therapeutic areas
Investing strategically in R&D
Have a history of strategic M&A activity
This detailed report is supported with over 365 tables & figures over 397 pages and profiles the main pharmacos in personalized medicine.
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1309114-personalized-medicine-targeted-therapeutics-companion-diagnostic-market-to-2021

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Smart Energy Market 2017 Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2022

Global Smart Energy Sales

PUNE, MAHARASHTRA, INDIA, May 30, 2017 /EINPresswire.com/ —

Global Smart Energy Sales Market Report 2017

Smart Energy market competition by top manufacturers/players, with Smart Energy sales volume, Price (USD/KW), revenue (Million USD) and market share for each manufacturer/player; the top players including

GE-Alstom
Itron
Siemens
ABB
S&T
Samsung SDI
A123
Bosch
BYD
Landis + Gyr
Sensus
AES Energy Storage
LG Chem
Saft
Axion Power International
Solar Grid Storage LLC

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1313507-global-smart-energy-sales-market-report-2017

Geographically, this report split global into several key Regions, with sales (MW), revenue (Million USD), market share and growth rate of Smart Energy for these regions, from 2012 to 2022 (forecast), covering

United States
China
Europe
Japan
Southeast Asia
India

On the basis of product, this report displays the sales volume (MW), revenue (Million USD), product price (USD/KW), market share and growth rate of each type, primarily split into

Independent Type Smart Energy
Distributed Smart Energy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Smart Energy for each application, including

Smart Grid
Digital Oilfield
Home Energy Management Systems (HEMS)
Smart Solar
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1313507-global-smart-energy-sales-market-report-2017

Table of Contents

Global Smart Energy Sales Market Report 2017
1 Smart Energy Market Overview
1.1 Product Overview and Scope of Smart Energy
1.2 Classification of Smart Energy by Product Category
1.2.1 Global Smart Energy Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Smart Energy Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Independent Type Smart Energy
1.2.4 Distributed Smart Energy
1.3 Global Smart Energy Market by Application/End Users

…CONTINUED

List of Tables and Figures

Figure Product Picture of Smart Energy
Figure Global Smart Energy Sales Volume Comparison (MW) by Type (2012-2022)
Figure Global Smart Energy Sales Volume Market Share by Type (Product Category) in 2016
Figure Independent Type Smart Energy Product Picture
Figure Distributed Smart Energy Product Picture
Figure Global Smart Energy Sales Comparison (MW) by Application (2012-2022)
Figure Global Sales Market Share of Smart Energy by Application in 2016
Figure Smart Grid Examples
Figure Digital Oilfield Examples

…CONTINUED

FOR ANY QUERY, CONTACT US @ https://www.wiseguyreports.com/enquiry/1313507-global-smart-energy-sales-market-report-2017

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Dermatology Diagnostic Device Market is Expected to Grow at a CAGR of 7% from 2016 to 2022

Dermatology Diagnostic Device Market by Diagnostic Device Type (dermatoscopes, microscopes), by Application, by End Users-Forecast to 2022

Major key Players include Valeant Pharmaceuticals,Alma Lasers,Cutera, Inc.,Lumenis, Ltd,Cynosure, Inc.,Genentech, Inc,Michelson Diagnostics Ltd.,Galderma S.A., ”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, May 30, 2017 /EINPresswire.com/ — Market Highlights
The global dermatology diagnostic device market has been evaluated as rapidly growing market and expected that the market will reach high growth figures. The benefits such as easy detection of the skin disease at the initial stages had increased their market globally. Dermatology diagnostic devices are widely accepted by the patient suffering from diseases like skin cancer, lesions, scalp problems, wrinkles, warts and other skin related diseases. Out of total cases of skin disease worldwide, US comprise around 6% of the cases while Europe comprises 7.5 % of the cases which are expected to increase during the forecast period, leading to the growth of the overall market. Technology advancements in treatments and increased incidences of skin diseases, acne, psoriasis, tattoo removal and other skin related problems are the major factors leading for the growth of market.

From 2010, there was huge growth reported in dermatology diagnostic devices, being developed or are commercially available in the market by more than 20 companies. Companies are now focusing on introducing a variety of advanced features to make the dermatology diagnostic device more user friendly such as self-use devices for lesion, warts and other skin related disease for patients.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/2154

Key players:
• Valeant Pharmaceuticals (Canada)
• Alma Lasers, Ltd. (Israel)
• Cutera, Inc. (U.S.)
• Lumenis, Ltd. (Israel),
• Cynosure, Inc. (U.S.),
• Dino-Lite Europe/IDCP B.V.
• Genentech, Inc., (US),
• Michelson Diagnostics Ltd., (UK),
• Galderma S.A., (Switzerland),
• Cutera, Inc. (US)

Asia Pacific is expected to be the fastest growing market and is expected to continue to grow at the same rate during the forecasted period.
Commenting on the report, an analyst from Market Research Future (MRFR)’s team said: the market for dermatology diagnostic device is growing rapidly due to technological advancement in treatment, increasing incidences of skin problems, awareness and concern regarding skin problems, and is expected to continue its growth in coming future. Increasing cases of various skin diseases, increasing prevalence of various chronic disease such as skin cancer along with rising demand of diagnosis and treatment are also attributing towards rising demand of dermatology devices in the coming future. Rising prevalence of skin cancer in Europe, Australia, New-Zealand and worldwide is leading to increase demand for diagnostic dermatology devices for early diagnosis and timely treatment of the disease.

Segments:
On the basis of the diagnostic device
• dermatoscopes,
• imaging devices,
• microscopes.
On the basis of application
• skin cancer
• lesion and others.
On the basis of end users
• hospitals
• research labs
• centers,
• institutions
• others

Test the market data and market information presented through more than 55 market data tables and figures spread over 85 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Dermatology diagnostic device market Research Report –Global Forecast to 2022”.
North America captures the largest market share of 70% in 2013 of the global dermatology diagnostic device market due to high prevalence of skin related diseases, and easy availability of dermatology diagnostic devices and treatment facilities which is possible because of the widespread healthcare infrastructure and government encouragement to medical innovation. It is expected to grow further during the forecasted period. Developing countries were reported to have maximum cases of skin disease but due to lack of technology advancement, skin care facilities, high cost of treatment, and lack of awareness, only few cases were reported and treated in the last 7 years.

Browse full report @ https://www.marketresearchfuture.com/reports/dermatology-diagnostic-device-market

Table of Content

1. Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4 Market Factor Analysis
Continue……

List of Tables
Table 1 Global Cardiac Rehabilitation Devices Market, By Type, 2013-2022 (Usd Million)
Table 2 Global Cardiac Rehabilitation Devices Market, By End User, 2013-2022 (Usd Million)
Table 3 Global Cardiac Rehabilitation Devices Market, By Region, 2013-2022 (Usd Million)
Continue…

Related Report
Cardiac rehabilitation devices market information, by type (recumbent cross trainer, treadmill, elliptical, stationary bicycle, training balls, heart rate monitors, blood flow monitors, and others), by end users (hospitals, clinic, cardiac care centers, rehab centers, and others) – Forecast to 2022.Know more about this report @ https://www.marketresearchfuture.com/reports/cardiac-rehabilitation-devices-market

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Nucleic Acid-based Therapeutics Market is Expected to Grow at a CAGR of 6.5% from 2016 to 2022

global Nucleic Acid-based Therapeutics market is expected to grow at a CAGR of ~6.5% during the period 2017 to 2023

Major key Players include Wave Life Sciences Ltd.,Copernicus Therapeutics Inc.,Imugene,Caperna,Phylogica,Protagonist Therapeutics,Benitec Biopharma,Benitec Biopharma,”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, May 30, 2017 /EINPresswire.com/ — Global Nucleic Acid Therapeutics market:
The global nucleic acid therapeutics market has been evaluated as a growing market and it is expected that the market will touch high growth figures in future. The global nucleic acid therapeutics market is expected to grow with CAGR of ~6.5% during the forecast period. Collaboration is the most effective strategy and first comer advantage is huge. Also, research funding by healthcare organizations and governments to develop advanced products is further expected to impel the growth

Key Players for Global Nucleic Acid-based Therapeutics Market:
• Wave Life Sciences Ltd.,
• Copernicus Therapeutics Inc.,
• Imugene,
• Caperna,
• Phylogica,
• Protagonist Therapeutics,
• Benitec Biopharma,
• EGEN (Expression Genetics),
• Benitec Biopharma,
• BioMedica (Oxford BioMedica),
• Transgene
• others.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/2978

Market Highlights
Nucleic acid therapeutics are analogues or inhibitors of naturally occurring nucleic acids or proteins responsible for genetic expression. They are intended to inhibit the expression of faulty proteins or to increase the expression of deficient proteins causing diseases.
Traditional drug therapy has poor or no cure for genetic diseases such as thalassemia, sickle cell anemia, hemophilia, cystic fibrosis, diabetes etc. Molecular target identification and genetic profiling forms the backbone of these class of drugs. The human genome project has also increased our understanding of the genetics. Nucleic acid medication have revolutionary potential as they target the genetic basis of diseases and can have permanent cure.

The market driving factors are the recent developments in genetics, the increasing economic and technological investments in research and development, poor cure rates for genetic diseases with traditional drugs, rising power of software’s to mimic the human molecular entities such as receptors etc.

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Nucleic Acid-based Therapeutics Market Research Report- Global Forecast to 2022”

The market restraints are prohibitive costs associated with the nucleic acid therapeutics, the ethical issues such as genetic contamination, and stringent regulatory environments etc. The death of Jesse Gelsinger, as a result of a gene therapy in 1999 highlighted the safety concerns with nucleic acid therapy.

The latest market trends include collaborations to reduce risks and to take advantage of each other’s technical expertise. The nucleic acid therapeutics market also is extremely supportive of contract research. Thus product development is the most effective strategy and any drug even with average safety level will be the market leader with minimum marketing costs and efforts.

Browse full report @ https://www.marketresearchfuture.com/reports/nucleic-acid-based-therapeutics-market-2978

Segmentation:
Global nucleic acid therapeutics market has been segmented
On the basis of technology which comprises anti-sense and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogs, ribozymes, aptamers and others.
On the basis of applications; market is segmented into monogenetic disorders which is further sub segmented into thalassemia, sickle cell anemia, hemophilia, cystic fibrosis etc. and multi-genetic disorders which is sub segmented into cancer, diabetes, neurodegenerative diseases, cardiovascular diseases etc.
On the basis of end users; market is segmented into hospitals, academic & research institutes.

The Hottest Trend in the Market
Nucleic medicines are targeted therapies designed to act on the molecular level. They are intended to correct for either the expression of a proteins causing disease or to correct for decreased protein expression in diseases.
The market for nucleic acid therapeutics is being driven by factors such as the intense expectation about their revolutionary potential, the potential extreme return on investment that can accrue, lack of effective treatment for genetic disorders with convectional drug therapy etc.
However, the market constraints are also serious which has limited the market. The technical barriers include lack of understanding of genetics and the extreme high development and time costs coupled with poor rates of success in developing newer nucleic acid drugs. The social barriers include issues of genetic contamination and other taboos associated with gene transfer. The regulatory hurdles are also strong and include issues of safety and ownership arising from genetic material.

Related Report
Cardiac rehabilitation devices market information, by type (recumbent cross trainer, treadmill, elliptical, stationary bicycle, training balls, heart rate monitors, blood flow monitors, and others), by end users (hospitals, clinic, cardiac care centers, rehab centers, and others) – Forecast to 2022.Know more about this report @ https://www.marketresearchfuture.com/reports/cardiac-rehabilitation-devices-market

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Denmark Beer Market Value, Volume, Trends, Growth, Regional Outlook and Forecast 2022 Market Reports

Denmark Beer Market-In-depth Analysis of Key Companies, Brands, Volume, Value and Segmentation Trends and Opportunities in the Beer Market

PUNE, INDIA, May 30, 2017 /EINPresswire.com/ — WiseGuyReports.com adds Exclusive Research on “Denmark Beer Market Insights Report 2016; In-depth Analysis of Key Companies, Brands, Volume, Value and Segmentation Trends and Opportunities in the Beer Market” reports to its database.

Summary
The Danish alcoholic beverages industry consumption fell by almost 89 th hl in 2015 where beer market showed a decline of more than 2%. The arrival and the interest in new specialty beers, the craft movement, more consciousness of health and demand for more of a taste experience have sparked new horizons in the Danish beer consumption pattern. Denmark has seen a shift away from high profile imported beers to domestically produced specialty beers. Seasonal beer continued its positive performance in 2015 as this type of beer is particularly popular and well received by consumers during festive seasons.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/737636-denmark-beer-market-insights-the-beer-market

Key Findings
– Demand for craft and other premium beers are strong in the Danish beer market.
– Imports increased in 2015 to make up 15% of overall sales.
– Royal Unibrew and Carlsberg are the leading exporters.
– Mainstream beer consumption remains the most popular segment, with 61% share of the market.
– A shift from beer to wine is expected in the longer term as Danes adopt a more continental lifestyle.

Synopsis
Denmark Beer Market Insights 2016 Report provides a complete overview of the Denmark beer industry structure offering a comprehensive insight into historical background trends, 2015 performance and 2016 outlook.

Covering total market (on and off-premise) the report details:
– 2011-2015 actual detailed beer consumption volume data by segment, brand, brewer, packaging and distribution (on-/off-premise), with 2016 forecasts
– Top line production, import, export and consumption volume from 2005-2015 with forecasts for 2016
– Value by distribution channel 2011-2015, with 2016 forecasts
– 2014-2016 selected on- / off-premise retail prices
– Details of key beer new product launches in 2015 by company
– Overview of the competitive landscape in the beer market, with analysis of key company performance
– Insightful and valuable analysis of the drivers behind both current and emerging trends in the beer market
– Data is also available in excel format

Reasons to Buy
– Gain an in-depth understanding of the dynamics and structure of the Denmark beer industry, from the latest competitive intelligence of both historical and forecast trends to enhance your corporate strategic planning
– Evaluate the current emerging trends and future growth opportunities in the Denmark beer market to support your brand development and marketing initiatives
– Understand volume vs. value trends and identify the key growth opportunities across the super-premium, premium, mainstream and discount segments to best target profitability
– Analyze domestic and imported beer brand performance and determine the key trends driving consumption preference to develop a competitive advantage
– Interrogate the unique granularity of our data to analyze the market on a variety of levels to make well-informed decisions on future threats and growth prospects in the marketplace for your company
– Use our new power point add-on to quickly absorb a succinct summary of the key trends in the Denmark beer market
– View a selection of the key 2015 product launches and identify competitor activity and product innovation and differentiation prospects

Table of Content: Key Points
1 Data Revisions Summary
2 Market Context
2.1 Market Parameters Tables
2.2 Legislation and Taxation Tables
3 Market Background Briefing
4 Market Update
4.1 New Products and Photo Shots
4.2 Beer Pricing Tables
4.3 Beer Data Tables
5 Brewer Profiles
6 Appendix
6.1 Disclaimer
6.2 Methodology, Wisdom Attributes & Product Definitions
6.3 Map

…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/737636-denmark-beer-market-insights-the-beer-market

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire